GlaxoSmithKline confirms Sir Philip Hampton to be chairman

UK pharma giant GlaxoSmithKline (LSE: GSK) this morning confirmed recent rumors, saying that Sir Philip Hampton will join the company’s board as non-executive director from January 1, 2015, and will become deputy chairman with effect from April 1, 2015.

Currently chairman of the Royal Bank of Scotland, Sir Philip will succeed Sir Christopher Gent as non-executive chairman with effect from September 1, 2015, or at an earlier date if released from other commitments. The appointment follows an extensive succession planning process undertaken by the Board over the last two years. The appointment of Sir Philip was recommended by the board’s Nominations Committee, chaired by Sir Deryck Maughan, GSK’s senior independent non-executive director.

Will oversee GSK comeback after scandals and profit warning